動脈スティフネス/動脈壁硬化:治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Arterial Stiffness Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Arterial Stiffness 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Arterial Stiffness to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Arterial Stiffness to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Arterial Stiffness 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Arterial Stiffness Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Kyushin Pharmaceutical Co., Ltd. 33
Clinical Trial Overview of Kyushin Pharmaceutical Co., Ltd. 33
Kyowa Hakko Europe GmbH 34
Clinical Trial Overview of Kyowa Hakko Europe GmbH 34
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Clinical Trial Overview of Top Institutes / Government 37
Assaf-Harofeh Medical Center 37
Clinical Trial Overview of Assaf-Harofeh Medical Center 37
University of Colorado 38
Clinical Trial Overview of University of Colorado 38
University of Alabama at Birmingham 39
Clinical Trial Overview of University of Alabama at Birmingham 39
St. Michael’s Hospital 40
Clinical Trial Overview of St. Michael’s Hospital 40
UMC Utrecht Holding BV 41
Clinical Trial Overview of UMC Utrecht Holding BV 41
University Hospital Inselspital, Berne 42
Clinical Trial Overview of University Hospital Inselspital, Berne 42
The University of Hong Kong 43
Clinical Trial Overview of The University of Hong Kong 43
Chinese University of Hong Kong 44
Clinical Trial Overview of Chinese University of Hong Kong 44
University of Florida 45
Clinical Trial Overview of University of Florida 45
Maastricht University Medical Center 46
Clinical Trial Overview of Maastricht University Medical Center 46
Five Key Clinical Profiles 47
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68


【レポート販売概要】

■ タイトル:動脈スティフネス/動脈壁硬化:治療薬のグローバル治験動向(2014年下半期)
■ 英文:Arterial Stiffness Global Clinical Trials Review, H2, 2014
■ 発行日:2014年8月25日
■ 調査会社:GlobalData
■ 商品コード:GDHC2313CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。